L3VLUP
ProSign in

RLAY · ARGX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

RLAYARGX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • RLAY
  • ARGX
0102030202120222023202420252026
Holders and value by quarter
QuarterRLAYARGX
Q3 20202 holders, $57m8 holders, $3.6bn
Q4 20204 holders, $23m7 holders, $4.1bn
Q1 20213 holders, $21m8 holders, $4.1bn
Q2 20212 holders, $18m9 holders, $4.6bn
Q3 20214 holders, $449m8 holders, $4.5bn
Q4 20214 holders, $515m9 holders, $5.3bn
Q1 20225 holders, $514m8 holders, $5.3bn
Q2 20224 holders, $16m13 holders, $6.5bn
Q3 20227 holders, $131m14 holders, $5.3bn
Q4 20223 holders, $16m13 holders, $5.5bn
Q1 20234 holders, $129m13 holders, $5.9bn
Q2 20233 holders, $8.6m18 holders, $6.6bn
Q3 20234 holders, $6.9m21 holders, $8.7bn
Q4 20234 holders, $12m17 holders, $6.3bn
Q1 20244 holders, $7.6m13 holders, $6.8bn
Q2 20244 holders, $5.8m14 holders, $7.9bn
Q3 20242 holders, $2.9m13 holders, $10.7bn
Q4 20241 holders, $447k14 holders, $12.3bn
Q1 20251 holders, $28m17 holders, $11.8bn
Q2 20251 holders, $47m18 holders, $10.8bn
Q3 20251 holders, $77m16 holders, $13.8bn
Q4 20253 holders, $127m16 holders, $14.8bn
Q1 2026none listed holders, n.a.11 holders, $12.3bn
Q2 20262 holders, $25m14 holders, $15.0bn
RLAY

Relay Therapeutics Inc

Holders
1
Reported value
$77m
Buyers
1
Sellers
0

Breadth +1 among 95 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
ARGX

Argenx Se

Holders
16
Reported value
$13.8bn
Buyers
10
Sellers
7

Breadth +3 among 95 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q3 2025

Among the 17 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Both (0)

No tracked manager lists every one of them.

Only RLAY (1)

Point72 Asset Management LP

Only ARGX (16)

Acadian Asset Management LLC, Artisan Partners LP, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Fidelity (FMR LLC), Hudson Bay Capital Management LP, Janus Henderson Group Ltd, Millennium Management LLC, Moore Capital Management LP, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Two Sigma Investments LP, Voloridge Investment Management LLC, Wellington Management Group LLP, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →